Invesaro

Stocks Comparison

Airsculpt Technologies vs LifeMD: revenue, profit, margins and growth compared

Airsculpt Technologies brought in $151.8M of revenue in fiscal 2025, LifeMD $194.1M in fiscal 2025. Revenue changed by -15.8% at Airsculpt Technologies and +25.3% at LifeMD on the year before, so LifeMD grew faster. Airsculpt Technologies kept -7.7% of its revenue as net profit, LifeMD 7.4%. Free cash flow was $692K at Airsculpt Technologies and $6.4M at LifeMD.

Side by side, latest fiscal year

AIRSLFMDP
Fiscal year endedFY2025 (December 31, 2025)FY2025 (December 31, 2025)
Revenue$151.8M$194.1M
Revenue growth-15.8%+25.3%
Net income-$11.7M$14.4M
Net margin-7.7%7.4%
Free cash flow$692K$6.4M
Free cash flow margin0.5%3.3%
Earnings per share (diluted)-$0.19$0.25
Cash$8.4M$36.8M
Debt$56Mn/a
Price to earningsn/a92.6
Market value$141.3M$1.1B
Dividend yieldn/an/a
Rank by revenue in sector#271 of 523 · Health care#253 of 523 · Health care

Over the years

Revenue
AIRS FY2019: $41.2MAIRS FY2021: $62.8MAIRS FY2021: $133.3MAIRS FY2022: $168.8MAIRS FY2023: $195.9MAIRS FY2024: $180.4MAIRS FY2025: $151.8MLFMDP FY2018: $8.3MLFMDP FY2019: $12.5MLFMDP FY2020: $37.3MLFMDP FY2021: $92.9MLFMDP FY2022: $119MLFMDP FY2023: $152.5MLFMDP FY2024: $154.8MLFMDP FY2025: $194.1MFY18FY19FY20FY21FY22FY23FY24FY25
AIRS $151.8MLFMDP $194.1M
Net income
AIRS FY2019: -$2.2MAIRS FY2021: $7.6MAIRS FY2021: $10.6MAIRS FY2022: -$14.7MAIRS FY2023: -$4.2MAIRS FY2024: -$8MAIRS FY2025: -$11.7MLFMDP FY2018: -$1.2MLFMDP FY2019: -$3.1MLFMDP FY2020: -$58.6MLFMDP FY2021: -$60.9MLFMDP FY2022: -$45.5MLFMDP FY2023: -$20.6MLFMDP FY2024: -$21.4MLFMDP FY2025: $14.4MFY18FY19FY20FY21FY22FY23FY24FY25
AIRS -$11.7MLFMDP $14.4M
Net margin
AIRS FY2019: -5.4%AIRS FY2021: 12.1%AIRS FY2021: 7.9%AIRS FY2022: -8.7%AIRS FY2023: -2.2%AIRS FY2024: -4.4%AIRS FY2025: -7.7%LFMDP FY2018: -14.9%LFMDP FY2019: -25.2%LFMDP FY2020: -157.3%LFMDP FY2021: -65.6%LFMDP FY2022: -38.3%LFMDP FY2023: -13.5%LFMDP FY2024: -13.8%LFMDP FY2025: 7.4%FY18FY19FY20FY21FY22FY23FY24FY25
AIRS -7.7%LFMDP 7.4%
Revenue growth
AIRS FY2021: +52.2%AIRS FY2021: +112.4%AIRS FY2022: +26.6%AIRS FY2023: +16.1%AIRS FY2024: -7.9%AIRS FY2025: -15.8%LFMDP FY2019: +49.8%LFMDP FY2020: +199.1%LFMDP FY2021: +149.0%LFMDP FY2022: +28.2%LFMDP FY2023: +28.2%LFMDP FY2024: +1.5%LFMDP FY2025: +25.3%FY19FY20FY21FY22FY23FY24FY25
AIRS -15.8%LFMDP +25.3%
Free cash flow
AIRS FY2019: $499KAIRS FY2021: $10.3MAIRS FY2021: $19.5MAIRS FY2022: $11.5MAIRS FY2023: $14MAIRS FY2024: -$2.7MAIRS FY2025: $692KLFMDP FY2021: -$33.3MLFMDP FY2022: -$23.3MLFMDP FY2023: $8.6MLFMDP FY2024: $16MLFMDP FY2025: $6.4MFY19FY21FY22FY23FY24FY25
AIRS $692KLFMDP $6.4M

Fiscal years as each company reports them; the two may end in different months.

Questions about Airsculpt Technologies and LifeMD

Which is bigger by revenue, Airsculpt Technologies or LifeMD?

LifeMD is bigger by revenue: $194.1M in fiscal 2025, against $151.8M for Airsculpt Technologies in fiscal 2025.

Which keeps more of its revenue as profit, Airsculpt Technologies or LifeMD?

Airsculpt Technologies had a net margin of -7.7% in fiscal 2025; LifeMD had 7.4% in fiscal 2025.

Which grew revenue faster, Airsculpt Technologies or LifeMD?

In their latest fiscal years revenue changed by -15.8% at Airsculpt Technologies and +25.3% at LifeMD.

Where do these numbers come from?

From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.

More comparisons

Compare more companies